Article
The effect of auricular acupuncture in obese women: a randomized controlled trial.
Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Journal of Women s Health (impact factor:
1.57).
06/2009;
18(6):813-8.
DOI:10.1089/jwh.2008.1005
pp.813-8
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: Gender differences in traditional Chinese medicine use among adults in Taiwan.
[show abstract] [hide abstract]
ABSTRACT: The increasing use of complementary, alternative medicine (CAM) and traditional Chinese medicine (TCM) has attracted attention. We report on the gender difference in TCM use among the general population in Taiwan in a population-based, cross-sectional study. We collected data on socio-demographic factors, lifestyle and health behavior from the 2001 Taiwan National Health Interview Survey. The medical records of interviewees aged 20-69 years were obtained from National Health Insurance claims data with informed consent. The prevalence of TCM use and the average frequency of TCM use were compared between women and men. Among 14,064 eligible participants, the one-year prevalence of TCM use for women and men was 31.8% and 22.4%, respectively. Compared with men, women had a higher average TCM use frequency (1.55 visits vs. 1.04 visits, p<0.001). This significant difference remained evident after excluding gender-specific diseases (1.43 visits vs. 1.03 visits, p<0.001). The average TCM use frequency was significantly higher in women than in men across all age groups. TCM use correlates differed for women and men. Marital status (odds ratio [OR] = 1.55, 95% confidence interval [CI] = 1.30-1.85), family income and unhealthy lifestyle (OR = 1.50, 95% CI = 1.30-1.74) were factors associated with TCM use in men but not in women. In Taiwan, women used more TCM services than men and the gender differences in the TCM use profile persisted across age groups.PLoS ONE 01/2012; 7(4):e32540. · 4.09 Impact Factor -
Article: Tackling obesity: new therapeutic agents for assisted weight loss.
[show abstract] [hide abstract]
ABSTRACT: The pandemic of overweight and obesity continues to rise in an alarming rate in western countries and around the globe representing a major public health challenge in desperate need for new strategies tackling obesity. In the United States nearly two thirds of the population is overweight or obese. Worldwide the number of persons who are overweight or obese exceeded 1.6 billion. These rising figures have been clearly associated with increased morbidity and mortality. For example, in the Framingham study, the risk of death increases with each additional pound of weight gain even in the relatively younger population between 30 and 42 years of age. Overweight and obesity are also associated with increased co-morbid conditions such as diabetes, hypertension and cardiovascular disease as well as certain types of cancer. In this review we discuss the epidemic of obesity, highlighting the pathophysiologic mechanisms of weight gain. We also provide an overview of the assessment of overweight and obese individuals discussing possible secondary causes of obesity. In a detailed section we discuss the currently approved therapeutic interventions for obesity highlighting their mechanisms of action and evidence of their efficacy and safety as provided in clinical trials. Finally, we discuss novel therapeutic interventions that are in various stages of development with a special section on the weight loss effects of anti-diabetic medications. These agents are particularly attractive options for our growing population of obese diabetic individuals.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 01/2010; 3:95-112.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
6 weeks
60 obese women
adverse effects
auricular acupuncture treatment
B. Group
body mass index
control group
group B
last 3 months
obese women
obesity-related hormone peptides
percent reductions
placebo needles
sham auricular acupuncture
short-term auricular acupuncture treatment
statistical difference
subjects' body weight
two groups
waist circumference
weight control maneuvers